Bull
$18.13
Scenario price
$8.420
-0.030 (-0.36%)At close
Chimera Investment Corporation is a diversified, internally managed real estate investment trust (REIT), that serves the United States residential real estate market. The Company operates through two segments, which include Investment Portfolio and Residential Origination. The Investment Portfolio segment consists of investments and third-party advisory service activities, which includes investments in financial assets including residential mortgage loans and properties, real estate-related securities, consumer loans, MSR-related investments and certain ancillary investments and equity method investments. The Residential Origination segment consists of the stand-alone mortgage origination business of HomeXpress that originates non-qualified mortgage (non-QM) residential mortgage loans (both consumer loans and Investor Loans), and other non-agency and agency mortgage loan products. The Company, through its segments, acquires, manages, finances and originates residential mortgages.
Chimera Investment Corp is currently trading at $8.42, which is significantly below the analyst price target of $13. However, the stock has a low RSI of 39.69, indicating it may be oversold, but the forward P/E of 5.29 suggests potential value. The recent performance shows a year-to-date decline of 33.91%, which raises concerns about its stability. Given these factors, it may be wise to hold off on buying until after the upcoming earnings report on November 5, 2026, to assess future performance more clearly.
Keefe Bruyette
$13
2026-10-07
Keefe Bruyette
2026-10-07
Price Target
$13
Keefe Bruyette
$14
2026-08-06
Keefe Bruyette
2026-08-06
Price Target
$14
RBC Capital
$13
2025-12-09
RBC Capital
2025-12-09
Price Target
$13
UBS
$16
2025-11-18
UBS
2025-11-18
Price Target
$16
Keefe Bruyette
$15
2025-07-10
Keefe Bruyette
2025-07-10
Price Target
$15
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Chimera Investment Corporation to Release Q3 Financial Results

Chimera Investment Corp Announces Preferred Stock Dividend

Chimera Investment Corp Announces Dividend for Preferred Stock

Analysis of Dividend Investment Value in REITs

Chimera Investment Reports Q2 2026 Earnings and Strategic Moves
Chimera Investment Corporation is a diversified, internally managed real estate investment trust (REIT), that serves the United States residential real estate market. The Company operates through two segments, which include Investment Portfolio and Residential Origination. The Investment Portfolio segment consists of investments and third-party advisory service activities, which includes investments in financial assets including residential mortgage loans and properties, real estate-related securities, consumer loans, MSR-related investments and certain ancillary investments and equity method investments. The Residential Origination segment consists of the stand-alone mortgage origination business of HomeXpress that originates non-qualified mortgage (non-QM) residential mortgage loans (both consumer loans and Investor Loans), and other non-agency and agency mortgage loan products. The Company, through its segments, acquires, manages, finances and originates residential mortgages. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).
Chimera Investment Corp is currently trading at $8.42, which is significantly below the analyst price target of $13. However, the stock has a low RSI of 39.69, indicating it may be oversold, but the forward P/E of 5.29 suggests potential value. The recent performance shows a year-to-date decline of 33.91%, which raises concerns about its stability. Given these factors, it may be wise to hold off on buying until after the upcoming earnings report on November 5, 2026, to assess future performance more clearly.
5 analysts cover CIM: 0 rate it Buy, 5 Hold and 0 Sell. The average price target is 14.50.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.